Alvogen is a privately owned pharmaceutical company founded in 2009 with headquarters in the United States. Employing approximately 570 people, the company operates globally, engaging in the development, manufacturing, and sale of generic drugs, branded pharmaceuticals, over-the-counter medications, and biosimilars.
On August 8, 2025, Alvogen partnered with Nosa Plugs AB publ to distribute Nozoil in Iceland. Alvogen employees participated in their 12th annual community service day on an unspecified date in Norwich, cleaning up the city. On August 12, 2025, the Northampton County Board of Supervisors approved a settlement involving Alvogen and other pharmaceutical companies, resulting in a $720 million payout to resolve opioid-related claims. Indiana also received $16.5 million as part of a nationwide settlement with Alvogen and seven other drug manufacturers over opioid-related claims, announced on an unspecified date.
Subscribe for full access to Alvogen's products in full detail 
